RankingsPricing
  1. US-listed companies
  2. NEUROCRINE BIOSCIENCES INC
  3. Financials
  4. Operating margin (%)

NEUROCRINE BIOSCIENCES INCNBIX

Market cap
$15.3B
P/E ratio
SummaryFinancials
Period EndOperating margin (%) YoY (%)
Dec 31, 20199.2+12.18%
Dec 31, 20188.2-110.06%
Dec 31, 2017-81.3-91.73%
Dec 31, 2016-982.5+106.18%
Dec 31, 2015-476.5-Infinity%
Dec 31, 20140-100.00%
Dec 31, 2013-1,701.9-62557.27%
Dec 31, 20122.7-93.78%
Dec 31, 201143.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)